Literature DB >> 28623447

New Approaches to Gastroesophageal Reflux Disease.

William Kethman1, Mary Hawn2.   

Abstract

BACKGROUND: Gastroesophageal reflux disease (GERD) is the most common gastrointestinal disorder of the esophagus. It is a chronic, progressive disorder that presents most typically with heartburn and regurgitation and atypically with chest pain, dysphagia, chronic cough, globus, or sore throat. The mainstay for diagnosis and characterization of the disorder is esophagoduodenoscopy (EGD), high-resolution esophageal manometry, and symptom-associated ambulatory esophageal pH impedance monitoring. Additional studies that can be useful in certain clinical presentations include gastric scintigraphy and oral contrast upper gastrointestinal radiographic series. DISCUSSION: Refractory GERD can be surgically managed with various techniques. In obese individuals, laparoscopic Roux-en-Y gastric bypass should be considered due to significant symptom improvement and lower incidence of recurrent symptoms with weight loss. Otherwise, laparoscopic Nissen fundoplication is the preferred surgical technique for treatment of this disease with concomitant hiatal hernia repair when present for either procedure. The short-term risks associated with these procedures include esophageal or gastric injury, pneumothorax, wound infection, and dysphagia. Emerging techniques for treatment of this disease include the Linx Reflux Management System, EndoStim LES Stimulation System, Esophyx® and MUSE™ endoscopic fundoplication devices, and the Stretta endoscopic ablation system. Outcomes after surgical management of refractory GERD are highly dependent on adherence to strict surgical indications and appropriate patient-specific procedure selection.

Entities:  

Keywords:  Advances; Endoscopy; Erosive esophagitis; Esophageal hypersensitivity; Functional heartburn; GERD; Gastroesophageal reflux disease; Nerd; Surgery

Mesh:

Year:  2017        PMID: 28623447     DOI: 10.1007/s11605-017-3439-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  41 in total

Review 1.  American Gastroenterological Association Institute technical review on the management of gastroesophageal reflux disease.

Authors:  Peter J Kahrilas; Nicholas J Shaheen; Michael F Vaezi
Journal:  Gastroenterology       Date:  2008-09-16       Impact factor: 22.682

Review 2.  The new kid on the block for advanced imaging in Barrett's esophagus: a review of volumetric laser endomicroscopy.

Authors:  Arvind J Trindade; Michael S Smith; Douglas K Pleskow
Journal:  Therap Adv Gastroenterol       Date:  2016-03-21       Impact factor: 4.409

3.  Histological consequences of gastroesophageal reflux in man.

Authors:  F Ismail-Beigi; P F Horton; C E Pope
Journal:  Gastroenterology       Date:  1970-02       Impact factor: 22.682

4.  Prevalence and socioeconomic impact of upper gastrointestinal disorders in the United States: results of the US Upper Gastrointestinal Study.

Authors:  Michael Camilleri; Dominique Dubois; Bernard Coulie; Michael Jones; Peter J Kahrilas; Anne M Rentz; Amnon Sonnenberg; Vincenzo Stanghellini; Walter F Stewart; Jan Tack; Nicholas J Talley; William Whitehead; Dennis A Revicki
Journal:  Clin Gastroenterol Hepatol       Date:  2005-06       Impact factor: 11.382

5.  Twelve months' follow-up after treatment with the EndoCinch endoscopic technique for gastro-oesophageal reflux disease: a randomized, placebo-controlled study.

Authors:  Madeleine Montgomery; Bengt Håkanson; Olle Ljungqvist; Bo Ahlman; Anders Thorell
Journal:  Scand J Gastroenterol       Date:  2006-12       Impact factor: 2.423

6.  Transoral endoscopic fundoplication in the treatment of gastroesophageal reflux disease: the anatomic and physiologic basis for reconstruction of the esophagogastric junction using a novel device.

Authors:  Blair A Jobe; Robert W O'Rourke; Barry P McMahon; Flemming Gravesen; Cedric Lorenzo; John G Hunter; Mary Bronner; Stefan J M Kraemer
Journal:  Ann Surg       Date:  2008-07       Impact factor: 12.969

Review 7.  Do endoscopic antireflux procedures fit in the current treatment paradigm of gastroesophageal reflux disease?

Authors:  John E Pandolfino; Kumar Krishnan
Journal:  Clin Gastroenterol Hepatol       Date:  2013-06-28       Impact factor: 11.382

8.  Multimodality evaluation of patients with gastroesophageal reflux disease symptoms who have failed empiric proton pump inhibitor therapy.

Authors:  G Galindo; J Vassalle; S N Marcus; G Triadafilopoulos
Journal:  Dis Esophagus       Date:  2012-08-02       Impact factor: 3.429

Review 9.  Refractory gastroesophageal reflux disease.

Authors:  Charumathi Raghu Subramanian; George Triadafilopoulos
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-09-30

10.  Long-term follow-up results of endoscopic treatment of gastroesophageal reflux disease with the MUSE™ endoscopic stapling device.

Authors:  Hong Joo Kim; Chang-Il Kwon; William R Kessler; Don J Selzer; Gail McNulty; Amol Bapaye; Luigi Bonavina; Glen A Lehman
Journal:  Surg Endosc       Date:  2015-11-04       Impact factor: 4.584

View more
  8 in total

Review 1.  The Great ESKAPE: Exploring the Crossroads of Bile and Antibiotic Resistance in Bacterial Pathogens.

Authors:  Kevin S Gipson; Kourtney P Nickerson; Eliana Drenkard; Alejandro Llanos-Chea; Snaha Krishna Dogiparthi; Bernard B Lanter; Rhianna M Hibbler; Lael M Yonker; Bryan P Hurley; Christina S Faherty
Journal:  Infect Immun       Date:  2020-09-18       Impact factor: 3.441

2.  [Esophageal pH-impedance monitoring of reflux patterns in non-erosive reflux disease, reflux hypersensitivity and functional heartburn].

Authors:  Ajing Zhang; Wenzhu Yao; Jia Di; Manli Cui; Mingxin Zhang; Jun Zhang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-10-30

3.  Traditional Chinese medicine based on Tongjiang methodology combined with proton pump inhibitor (PPI) step-down in treating non-erosive reflux disease: a study protocol for a multicentered, randomized controlled clinical trial.

Authors:  Xia Li; Haomeng Wu; Beihua Zhang; Ting Chen; Xiaoshuang Shi; Jinxin Ma; Jiaqi Zhang; Xudong Tang; Fengyun Wang
Journal:  Trials       Date:  2022-10-18       Impact factor: 2.728

4.  Can Omentopexy Reduce the Incidence of Gastroesophageal Reflux Disease After Laparoscopic Sleeve Gastrectomy.

Authors:  Saeid Shams Nosrati; Abdolreza Pazouki; Mohammad Sabzikarian; Mohammadali Pakaneh; Ali Kabir; Mohammad Kermansaravi
Journal:  Obes Surg       Date:  2020-08-18       Impact factor: 4.129

Review 5.  Clinical efficacy and safety of magnetic sphincter augmentation (MSA) and transoral incisionless fundoplication (TIF2) in refractory gastroesophageal reflux disease (GERD): a systematic review and meta-analysis.

Authors:  Saurabh Chandan; Babu P Mohan; Shahab R Khan; Lokesh K Jha; Amaninder J Dhaliwal; Mohammad Bilal; Muhammad Aziz; Andrew Canakis; Sumant Arora; Sarah Malik; Lena L Kassab; Suresh Ponnada; Ishfaq Bhat; Alexander T Hewlett; Neil Sharma; Stephanie McDonough; Douglas G Adler
Journal:  Endosc Int Open       Date:  2021-04-13

6.  Long-term reported outcomes of transoral incisionless fundoplication: an 8-year cohort study.

Authors:  Munyaradzi Chimukangara; Anahita D Jalilvand; W Scott Melvin; Kyle A Perry
Journal:  Surg Endosc       Date:  2018-08-27       Impact factor: 4.584

Review 7.  Efficacy and Safety of Esomeprazole for the Treatment of Reflux Symptoms in Patients with Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis.

Authors:  Mingxing Hou; Haiqing Hu; Chunlu Jin; Xuemei Yu
Journal:  Iran J Public Health       Date:  2020-12       Impact factor: 1.429

8.  Efficacy and safety of traditional Chinese herbal formula combined with western medicine for gastroesophageal reflux disease: A protocol for systematic review and meta-analysis.

Authors:  Wuhong Lin; Guihua Huang; Xirong Liu; Huasheng Lin; Heng Zhou; Chunbing Feng; Tingshuai Wang; Renjiu Liang
Journal:  Medicine (Baltimore)       Date:  2020-10-09       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.